-
The Safety of Topiroxostat
Time of Update: 2023-04-29
The potential for reactivity and toxicity of topiroxostat makes it important to follow proper storage and handling procedures.
The potential for reactivity and toxicity of topiroxostat makes it important to follow proper storage and handling procedures.
-
The largest study to date found no link between prenatal anesthesia and impaired neurodevelopmental development in children
Time of Update: 2022-10-31
S. Food and Drug Administration (FDA) issued a warning in 2016 that repeated or prolonged use of general anesthesia by pregnant women in the third trimester of pregnancy could lead to impaired neurodevelopment in children exposed to general anesthesia.
-
Clarify your responsibilities! Many places have made it clear that the prevention and control of the cold chain food epidemic is the responsibility of the commerce department
Time of Update: 2022-10-04
The Department of Commerce of Sichuan Province on doing a good job in the epidemicNotice on the work related to the commercial and trade service industry under the condition of normalization of preven
-
Alzheimer's disease may usher in a landmark treatment! In-depth interpretation of the important results of AAIC 2022, Subcutaneous injection therapy for Alzheimer's disease is expected to slow down
Time of Update: 2022-09-21
Professor Wang Yanjiang, director of the Department of Neurology at Daping Hospital of the Army Military Medical University, told Singularity Network, "This study gives us a new understanding of the cognitive improvement effect of high-dose Gantenerumab treatment.
-
Excellent adhesion of new generation medical TPE to various engineering plastics
Time of Update: 2022-08-25
Medical devices with soft contact materials (gray)"The lagging of Medalist TPE's soft and rigid substrates enhances the ergonomic and aesthetic properties of medical devices, adds new features such as molded seals and molded cushions, provides product design freedom and Product cost savings,” said Ross van Royen, Senior Marketing Manager, Teknor Apex.
-
GSK adjuvant recombinant new crown vaccine enters Phase 3 clinical trials
Time of Update: 2021-05-31
com/en-us/media/press-releases/gsk-and-vir-biotechnology-announce-sotrovimab-vir-7831-receives-emergency-use-authorization-from-the -us-fda/ On May 27, local time, GlaxoSmithKline (GSK) announced that it has launched a phase 3 clinical trial of the adjuvant recombinant COVID-19 candidate vaccine developed in cooperation with Sanofi (SNF), which is expected to be in the United States, Asia, and Africa.
-
JAMA sub-issue: "Responding to Challenges, Lasting Innovation" FDA officials talk about cancer research in pandemics
Time of Update: 2020-10-30
authors argue that the COVID-19 pandemic has generated data on how anti-tumor drugs are used outside of traditional clinical trial environments, and that responding to emergencies has forced a reassessment of endpoint assessments to accelerate patient-centered outcomes.
-
Insys's medicinal cannabis diphenol has been recognized by FDA as an orphan drug
Time of Update: 2014-07-03
Source: insys therapeutics, a professional pharmaceutical company developing innovative drugs and new drug delivery systems under the China Council for the promotion of drugs on July 3, 2014, announce
